Merck & Co., Inc.:企業のM&A・事業提携・投資動向

◆英語タイトル:Merck & Co., Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2095
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:505
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Merck & Co., Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Merck & Co., Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Merck & Co., Inc. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Merck & Co., Inc.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Merck & Co., Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Merck & Co., Inc.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Merck & Co., Inc. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Merck & Co., Inc.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Merck & Co., Inc.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
TARGETS AND PARTNERS 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Overview 7
Mergers and Acquisitions – Deal reports 8
CORPORATE VENTURING 20
Corporate Venturing – Overview 20
Corporate Venturing – Deal reports 21
PARTNERSHIP 32
Partnership – Overview 32
Partnership – Deal reports 33
DIVESTMENTS 474
Divestments – Overview 474
Divestments – Deal reports 475
APPENDIX 495
Contact Us 495
About MarketLine Financial Deals Database 495
Deal Definition and Methodology 497
About MarketLine 504

List of Tables
Table 1: Merck & Co. M&A volume and value trend (2014-YTD2018)
Table 2: Merck & Co. M&A activity by geography (2014-YTD2018)
Table 3: Merck & Co. corporate venturing volume and value trend (2014-YTD2018)
Table 4: Merck & Co. corporate venturing by geography (2014-YTD2018)
Table 5: Merck & Co. partnership volume and value trend (2014-YTD2018)
Table 6: Merck & Co. partnership trend by key deal type (2014-YTD2018)
Table 7: Merck & Co. divestments volume and value trend (2014-YTD2018)
Table 8: Merck & Co. divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Merck & Co. M&A volume and value trend (2014-YTD2018)
Figure 2: Merck & Co. M&A activity by geography (2014-YTD2018)
Figure 3: Merck & Co. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Merck & Co. corporate venturing by geography (2014-YTD2018)
Figure 5: Merck & Co. partnership volume and value trend (2014-YTD2018)
Figure 6: Merck & Co. partnership trend by key deal type (2014-YTD2018)
Figure 7: Merck & Co. divestments volume and value trend (2014-YTD2018)
Figure 8: Merck & Co. divestments by geography (2014-YTD2018)

★海外企業調査レポート[Merck & Co., Inc.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chiyoda Corporation:企業の戦略・SWOT・財務情報
    Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report Summary Chiyoda Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …
  • Bouygues Group:戦略・SWOT・企業財務分析
    Bouygues Group - Strategy, SWOT and Corporate Finance Report Summary Bouygues Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Fibria Celulose S.A.:企業の戦略・SWOT・財務情報
    Fibria Celulose S.A. - Strategy, SWOT and Corporate Finance Report Summary Fibria Celulose S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Austevoll Seafood ASA:企業の戦略・SWOT・財務情報
    Austevoll Seafood ASA - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Donaldson Co Inc (DCI):企業の財務・戦略的SWOT分析
    Donaldson Co Inc (DCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Wns (Holdings) Limited:企業の戦略・SWOT・財務分析
    Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Wns (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). Its …
  • First Midwest Bancorp, Inc.:企業の戦略・SWOT・財務情報
    First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary First Midwest Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Air Products and Chemicals Inc (APD)-石油・ガス分野:企業M&A・提携分析
    Summary Air Products and Chemicals Inc (Air Products) is an industrial gases company. It provides a portfolio of products, services, and solutions that include atmospheric, process and specialty gases, electronics and performance materials, and equipment. The company supplies oxygen, nitrogen, argon …
  • Surteco SE (SUR):企業の財務・戦略的SWOT分析
    Surteco SE (SUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc is a biopharmaceutical company that offers research, development and commercialization of prescription drugs. The company offers products such as Onemia and CaPre. Its CaPre is developed for the prevention a …
  • TherOx Inc:医療機器:M&Aディール及び事業提携情報
    Summary TherOx Inc (TherOx) is a medical device company that develops and commercializes SuperSaturated Oxygen (SSO2) therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherO …
  • Graham Holdings Company (GHC):企業の財務・戦略的SWOT分析
    Graham Holdings Company (GHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kier Group plc:企業のM&A・事業提携・投資動向
    Kier Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kier Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Rhizen Pharmaceuticals SA-製薬・医療分野:企業M&A・提携分析
    Summary Rhizen Pharmaceuticals SA (Rhizen Pharma), a subsidiary of Alembic Pharmaceuticals Ltd is a biopharmaceutical company that discovers and develops small molecule drugs. The company’s research products includes c-Met inhibitors, selective P13K inhibitors, CRAC channel inhibitors and GPR 119 ag …
  • Bausch Health Companies Inc (BHC):企業の財務・戦略的SWOT分析
    Bausch Health Companies Inc (BHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Croma-Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Croma-Pharma GmbH (Croma Pharma) is a pharmaceutical company that offers development and commercialization of drugs in the field of aesthetic dermatology. The company’s products include princess skincare, princess injectables, and princess lift products. Its princess skincare products compri …
  • Rottneros AB (RROS):企業の財務・戦略的SWOT分析
    Rottneros AB (RROS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆